Steven T. Szabo, Ph.D.
Affiliations: | McGill University, Montreal, QC, Canada |
Google:
"Steven Szabo"Mean distance: 19.55 (cluster 11)
Parents
Sign in to add mentor| Pierre Blier | grad student | 2002 | McGill | |
| (Interactions between serotonergic and noradrenergic systems: Their involvement in antidepressant treatment of anxiety and affective disorders.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Krystal AD, Pizzagalli DA, Smoski M, et al. (2020) A randomized proof-of-mechanism trial applying the 'fast-fail' approach to evaluating κ-opioid antagonism as a treatment for anhedonia. Nature Medicine |
| Mischel NA, Kritzer MD, Patkar AA, et al. (2019) Updates on Preclinical and Translational Neuroscience of Mood Disorders: A Brief Historical Focus on Ketamine for the Clinician. Journal of Clinical Psychopharmacology. 39: 665-672 |
| Banov MD, Young JR, Dunn T, et al. (2019) Efficacy and safety of ketamine in the management of anxiety and anxiety spectrum disorders: a review of the literature. Cns Spectrums. 1-12 |
| Szabo ST, Thorpy MJ, Mayer G, et al. (2018) Neurobiological and immunogenetic aspects of narcolepsy: Implications for pharmacotherapy. Sleep Medicine Reviews. 43: 23-36 |
| Kumar S, Black SJ, Hultman R, et al. (2013) Cortical control of affective networks. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 1116-29 |
| Lee TH, Szabo ST, Fowler JC, et al. (2012) Pharmacologically-mediated reactivation and reconsolidation blockade of the psychostimulant-abuse circuit: a novel treatment strategy. Drug and Alcohol Dependence. 124: 11-8 |
| Bhatia KS, Szabo ST, Fowler JC, et al. (2011) Reversal of long-term methamphetamine sensitization by combination of pergolide with ondansetron or ketanserin, but not mirtazapine. Behavioural Brain Research. 223: 227-32 |
| Szabo ST, Machado-Vieira R, Yuan P, et al. (2009) Glutamate receptors as targets of protein kinase C in the pathophysiology and treatment of animal models of mania. Neuropharmacology. 56: 47-55 |
| Einat H, Yuan P, Szabo ST, et al. (2007) Protein kinase C inhibition by tamoxifen antagonizes manic-like behavior in rats: implications for the development of novel therapeutics for bipolar disorder. Neuropsychobiology. 55: 123-31 |
| Blier P, Szabo ST. (2005) Potential mechanisms of action of atypical antipsychotic medications in treatment-resistant depression and anxiety. The Journal of Clinical Psychiatry. 66: 30-40 |